Bioventix PLC (AIM:BVXP)
London · Delayed Price · Currency is GBP · Price in GBX 2,050.00
+150.00 (7.89%)
Oct 31, 2025, 4:41 PM GMT+1
Bioventix Market Cap
Bioventix has a market cap or net worth of 107.11 million as of October 31, 2025. Its market cap has decreased by -43.39% in one year.
Market Cap
107.11M
Enterprise Value
102.03M
Revenue
13.12M
Ranking
n/a
PE Ratio
14.31
Stock Price
2,050.00
Market Cap Chart
Since April 8, 2010, Bioventix's market cap has increased from 9.85M to 107.11M, an increase of 987.68%. That is a compound annual growth rate of 16.56%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 31, 2025 | 107.11M | -35.37% |
| Dec 31, 2024 | 165.72M | -26.16% |
| Dec 29, 2023 | 224.45M | 7.98% |
| Dec 30, 2022 | 207.85M | 17.35% |
| Dec 31, 2021 | 177.12M | -22.46% |
| Dec 31, 2020 | 228.43M | 34.19% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 193.37B |
| GSK plc | 71.57B |
| Haleon | 31.54B |
| Smith & Nephew | 11.91B |
| ConvaTec Group | 4.85B |
| Hikma Pharmaceuticals | 4.07B |
| HUTCHMED (China) | 1.89B |
| Genus | 1.65B |